Human CD26high T cells elicit tumor immunity against multiple malignancies via enhanced migration and persistence

Human CD26high T cells elicit tumor immunity against multiple malignancies via enhanced migration and persistence

The role of human CD4+ T cell subsets in cancer immunotherapy is still unclear. Here, the authors show that CD26 identifies three CD4+ T cell subsets with distinct immunological properties in both healthy individuals and cancer patients.

Bibliographic Details
Main Authors: Stefanie R. Bailey, Michelle H. Nelson, Kinga Majchrzak, Jacob S. Bowers, Megan M. Wyatt, Aubrey S. Smith, Lillian R. Neal, Keisuke Shirai, Carmine Carpenito, Carl H. June, Michael J. Zilliox, Chrystal M. Paulos
Format: Article
Language:English
Published: Nature Publishing Group 2017-12-01
Series:Nature Communications
Online Access:https://doi.org/10.1038/s41467-017-01867-9

Internet

https://doi.org/10.1038/s41467-017-01867-9

Similar Items